Salt Lake City, UT, United States of America

Bradford C VanWagenen


Average Co-Inventor Count = 3.7

ph-index = 5

Forward Citations = 89(Granted Patents)


Company Filing History:


Years Active: 1995-2003

Loading Chart...
11 patents (USPTO):Explore Patents

Title: Bradford C. VanWagenen: Pioneering Innovations in Neurological Treatments

Introduction

Bradford C. VanWagenen, an accomplished inventor based in Salt Lake City, UT, has made significant contributions to the field of pharmacology, specifically in the development of compounds for neurological disorders. With a total of 11 patents to his name, he is recognized for his innovative approaches to treating conditions such as epilepsy, anxiety, and other central nervous system-related issues.

Latest Patents

Among his latest innovations are the patents for "Anticonvulsant and central nervous system-depressing bis(fluorophenyl)alkylamides and their uses." These bis(fluorophenyl)alkylamides have been synthesized to exhibit effective pharmacological properties beneficial in treating neurological diseases, including epilepsy and seizure disorders. One of the key advantages of these compounds is their low sedation effect and high therapeutic indices, promising once-a-day dosing for patients.

Another of his key inventions is a method for identifying compounds that can effectively target receptor-operated calcium channels for the treatment of a range of neurological diseases. This includes potentially treating conditions such as stroke, spinal cord injury, and neurodegenerative diseases like Alzheimer's and Parkinson's. The innovative methodology can lead to better therapeutic options for affected patients, enhancing overall treatment efficacy.

Career Highlights

Throughout his career, Bradford C. VanWagenen has worked with prominent companies, including NPS Pharmaceuticals, Inc. and FMC Corporation, where he has collaborated on various innovative drug developments. His contributions have been instrumental in driving advancements in the treatment options available for neurological conditions.

Collaborations

VanWagenen has had the opportunity to work alongside talented individuals such as Alan L. Mueller and Manuel F. Balandrin. Together, they have explored novel avenues in pharmacology, further enhancing the landscape of neurological therapeutics.

Conclusion

Bradford C. VanWagenen exemplifies the spirit of innovation within the pharmaceutical industry. His dedication to improving therapies for neurological disorders through targeted research and development is a testament to his impact as an inventor. As he continues to advance his work, VanWagenen remains a pivotal figure in the quest for effective treatments for patients suffering from debilitating conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…